All filters
Slidesets
Consideration regarding the service model on pre-exposure prophylaxis for men who have sex with men in the community- Dr. T.H. Kwan
Presented at:
APACC 2017
Slidesets
Pre-exposure prophylaxis uptake among men who have sex with men at a clinic in Bangkok, Thailand, 2016- Dr. W. Wimonsate
Presented at:
APACC 2017
Slidesets
Population-based PrEP implementation in New South Wales, Australia- Andrew Grulich
Presented at:
APACC 2017
Slidesets
Round Table Discussion: True demand from the communities- Midnigh Poonkasetwattana
Presented at:
APACC 2017
Slidesets
Round Table Discussion: Genuine supply from the providers- Rossana Ditangco
Presented at:
APACC 2017
Slidesets
Access to treatment/care on the global level- Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD
Presented at:
APACC 2017
Slidesets
Innovative ways to stimulate the demand of HIV and HCV testing- Philip Cunningham
Presented at:
APACC 2017
Slidesets
Sensitive Detection of Tenofovir-induced Tubular Injury with Urinary ß-2 Microglobuline in Vietnam | Daisuke Mizushima
Presented at:
APACC 2016
Slidesets
Tenofovir-induced kidney tubular dysfunction in HIV-infected patients in Hong Kong | Denise Chan
Presented at:
APACC 2016
Slidesets
Using the HVTN model to conduct HIV vaccine clinical trials | Xia Jin, MD, PhD
Presented at:
APACC 2016
Slidesets
Safety and efficacy of tenofovir disoproxil fumarate plus emtricitabine for HIV pre-exposure prophylaxis in Thailand | Donn Colby, MD, MPH
Presented at:
APACC 2016
Slidesets
Long Acting Antivirals for Treatment and Prevention | Martin Markowitz, MD
Presented at:
APACC 2016
Slidesets
Towards an HIV Cure; clinical strategies and trials | Jintanat Ananworanich, MD, PhD
Presented at:
APACC 2016